The FDA is reportedly about to make approving a coronavirus vaccine before the election a lot tougher
The Food and Drug Administration is poised to roll out new, rigorous standards for an emergency approval for a coronavirus vaccine, The Washington Post reports.
The standards, which appear to be an example of the agency's efforts to increase public trust amid the politicization of vaccine development, could be unveiled as soon as this week and are expected to be much tougher than what was used for the controversial emergency clearances of potential COVID-19 treatments hydroxychloroquine and convalescent plasma, per the Post. Manufacturers will be asked to follow vaccine trial participants for at least two months after they receive their second shot, two individuals familiar with situation told the Post on condition of anonymity. The agency will also reportedly be looking for at least five severe COVID-19 cases in the placebo group for each trial, as well as some cases of the disease in older people to see if the vaccine works.
Given the new standards, plus the time it will take companies developing vaccine candidates to apply for an emergency use authorization and for the FDA to review the data, "it's hard to imagine how an EUA could possibly occur before December," Paul Offit, the director of the Vaccine Education Center at Children's Hospital of Philadelphia and FDA vaccine advisory board member, told the Post.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
That will likely allay at least some fears that the White House will try to push a vaccine out before the November election, although there are some people who think the FDA shouldn't grant an EUA for a vaccine at all since there'd still be less safety data required for approval than under normal circumstances. Read more at The Washington Post.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Unpasteurised milk and the American right
Under the radar Former darling of health-conscious liberal foodies is now a 'conservative culture war signal': a sign of mistrust in experts
By Harriet Marsden, The Week UK Published
-
Government shutdown looming? Blame the border
Talking Points Democrats and Republicans say funding for immigration enforcement is the budget battle's latest sticking point. That's about all they agree on.
By Rafi Schwartz, The Week US Published
-
'Conservatives have not limited their attack on reproductive rights to the US'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Putin's preordained win marred by protests
speed read Voters participated in a silent protest — endorsed by late opposition leader Alexei Navalny — against the president
By Peter Weber, The Week US Published
-
Trump's 'bloodbath' rhetoric draws scrutiny
speed read In a new speech, the former president seemingly promises violence if he loses the election
By Peter Weber, The Week US Published
-
Iran at the crossroads: have the mullahs lost their grip?
In Depth Iranian voters delivered a 'stinging rebuke' to the regime in parliamentary elections
By The Week UK Published
-
Russians start to vote in election Putin will win
speed read Putin's opponents are mostly in prison, exiled or dead
By Peter Weber, The Week US Published
-
Schumer slams Netanyahu, calls for new leader
speed read The senator — one of Israel's most avid supporters — criticized the country's handling of the Gaza war
By Peter Weber, The Week US Published
-
South Dakota governor sued over Texas dentist promo
speed read Gov. Kristi Noem posted a video testimonial that may have been an "undisclosed advertisement"
By Peter Weber, The Week US Published
-
The state of Russian opposition after Navalny
The Explainer Potential challengers to Vladimir Putin have been jailed, exiled or barred from ballot
By Harriet Marsden, The Week UK Published
-
Hur defends description of Biden's 'poor memory'
speed read Former special counsel Robert Hur defended disparaging remarks made about Biden's age in his report
By Peter Weber, The Week US Published